Maria Teresa Garcia-Gonzalez

Dr. Maria Teresa Garcia-Gonzalez

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2020 in Entropy
Verified
Journal Article
Open access
PDF file
JRJosé Javier Reyes-Lagos
José Javier Reyes-Lagos
APAdriana Cristina Pliego
Adriana Cristina Pliego
CLClaudia Ivette Ledesma-Ramírez
Claudia Ivette Ledesma-Ramírez
MPMiguel Ángel Peña-Castillo
Miguel Ángel Peña-Castillo
MGMaria Teresa Garcia-Gonzalez
Maria Teresa Garcia-Gonzalez
JEJC Echeverría
JC Echeverría
Phase Entropy (PhEn) was recently introduced for evaluating the nonlinear features of physiological time series. PhEn has been demonstrated to be a robust approach in comparison to other entropy-based methods to achieve this goal. In this context, the present study aimed to analyze the nonlinear features of raw electrohysterogram (EHG) time series collected from women at the third trimester of pregnancy (TT) and later during term active parturition (P) by PhEn. We collected 10-min longitudinal transabdominal recordings of 24 low-risk pregnant women at TT (from 35 to 38 weeks of pregnancy) and P (>39 weeks of pregnancy). We computed the second-order difference plots (SODPs) for the TT and P stages, and we evaluated the PhEn by modifying the k value, a coarse-graining parameter. Our results pointed out that PhEn in TT is characterized by a higher likelihood of manifesting nonlinear dynamics compared to the P condition. However, both conditions maintain percentages of nonlinear series higher than 66%. We conclude that the nonlinear features appear to be retained for both stages of pregnancy despite the uterine and cervical reorganization process that occurs in the transition from the third trimester to parturition.

1 August 2026 in Academic Journal of Health Sciences
Verified
Journal Article
Closed access
ATAntonio Torres-Palacios
Antonio Torres-Palacios
MGMaría Gil-Llinás
María Gil-Llinás
JMJuan Antonio Roberto Martín
Juan Antonio Roberto Martín
ASAntonio Serra-Capó
Antonio Serra-Capó
ETEduardo Tejedo-Benedicto
Eduardo Tejedo-Benedicto
MGMaria Teresa Garcia-Gonzalez
Maria Teresa Garcia-Gonzalez
Background: Body mass index (BMI) is widely used to assess obesity and cardiometabolic risk, but it does not account for fat distribution. Visceral adiposity plays a central role in metabolic dysfunction, and reliance on BMI alone may lead to misclassification of risk. Objective: To evaluate the extent to which BMI underestimates cardiometabolic risk compared with an index of visceral adiposity (METS-VF) in a large working population, and to identify population subgroups in which this underestimation is more pronounced. Methods: A cross-sectional study was conducted in 154,327 working-age adults undergoing routine occupational health examinations. Cardiometabolic risk was assessed using BMI and METS-VF. Misclassification was defined as discordance between both measures, with underestimation corresponding to individuals classified as low risk by BMI but high risk by METS-VF. Multivariable logistic regression models were used to identify factors associated with underestimation. Results: Overall, 18.7% of participants were misclassified, with underestimation representing the predominant pattern (14.9%). Agreement between BMI and METS-VF was moderate (kappa = 0.56). Underestimation was more frequent among women (17.8% vs 12.3%), increased with age (from 10.6% to 19.7%), and was more prevalent in individuals with lower educational attainment and manual occupations. In adjusted analyses, female sex (OR 1.42, 95% CI 1.38–1.47), older age (OR 1.18 per 10 years), and lower socioeconomic position were independently associated with underestimation. BMI showed moderate sensitivity (68.4%) but high specificity (91.2%) for detecting cardiometabolic risk. Conclusions: BMI substantially underestimates cardiometabolic risk compared with indices reflecting visceral adiposity. This limitation is particularly relevant among women, older individuals, and socially disadvantaged groups. Incorporating alternative measures of adiposity may improve risk detection and contribute to more equitable prevention strategies.

3 November 2025 in Arandu UTIC
Verified
Journal Article
Open access
PDF file
NVNubia Denisse Nieto Vargas
Nubia Denisse Nieto Vargas
NMNoemi Altagracia Enciso Modesto
Noemi Altagracia Enciso Modesto
MGMaria Teresa Garcia-Gonzalez
Maria Teresa Garcia-Gonzalez
Miguel Alberto Gutiérrez-NavaMiguel Alberto Gutiérrez-Nava
Miguel Alberto Gutiérrez-Nava
CTCesar Rafael Meza Torres
Cesar Rafael Meza Torres
Este artículo es una revisión sistemática del uso de plantas medicinales en el tratamiento de la hiperplasia benigna de próstata (HBP). Se revisaron diferentes plantas, destacando Pygeum africanum, Serenoa repens, Cucurbita pepo y Urtica, por su probable eficacia en la reducción de síntomas urinarios asociados con la HBP. A través de una revisión sistemática de ensayos controlados aleatorizados, se puede observar que, aunque los usos de estas plantas muestran mejoría en los síntomas, su eficacia comparativa con medicamentos convencionales como los bloqueadores alfa-adrenérgicos y los inhibidores de la 5-alfa-reductasa sigue siendo poco clara. En su mayoría estos estudios presentan limitaciones metodológicas, lo que sugiere la necesidad de nuevas investigaciones con un mejor diseño. Este análisis enfatiza la importancia de considerar tratamientos con plantas como una alternativa viable.